Detailed Information on Publication Record
2020
Bi-allelic ADARB1 Variants Associated with Microcephaly, Intellectual Disability, and Seizures
TAN, Tiong Yang, Jiří SEDMÍK, Mark P. FITZGERALD, Rivka SUKENIK HALEVY, Liam KEEGAN et. al.Basic information
Original name
Bi-allelic ADARB1 Variants Associated with Microcephaly, Intellectual Disability, and Seizures
Authors
TAN, Tiong Yang, Jiří SEDMÍK (203 Czech Republic, belonging to the institution), Mark P. FITZGERALD, Rivka SUKENIK HALEVY, Liam KEEGAN (372 Ireland, belonging to the institution), Ingo HELBIG, Lina BASEL-SALMON, Lior COHEN, Rachel STRAUSSBERG, Wendy K. CHUNG, Mayada HELAL, Reza MAROOFIAN, Henry HOULDEN, Jane JUUSOLA, Simon SADEDIN, Lynn PAIS, Katherine B. HOWELL, Susan M. WHITE, John CHRISTODOULOU and Mary Anne O'CONNELL (372 Ireland, guarantor, belonging to the institution)
Edition
The American Journal of Human Genetics, University of Chicago Press for the American Society of Human Genetics, 2020, 0002-9297
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10608 Biochemistry and molecular biology
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 11.025
RIV identification code
RIV/00216224:14740/20:00114081
Organization unit
Central European Institute of Technology
UT WoS
000523306000005
Keywords in English
ADAR2; microcephaly; migrating focal seizures; epilepsy; intellectual disability; RNA editing
Tags
International impact, Reviewed
Změněno: 9/10/2024 12:25, Mgr. Adéla Pešková
Abstract
V originále
The RNA editing enzyme ADAR2 is essential for the recoding of brain transcripts. Impaired ADAR2 editing leads to early-onset epilepsy and premature death in a mouse model. Here, we report bi-allelic variants in ADARB1, the gene encoding ADAR2, in four unrelated individuals with microcephaly, intellectual disability, and epilepsy. In one individual, a homozygous variant in one of the double-stranded RNA-binding domains (dsRBDs) was identified. In the others, variants were situated in or around the deaminase domain. To evaluate the effects of these variants on ADAR2 enzymatic activity, we performed in vitro assays with recombinant proteins in HEK293T cells and ex vivo assays with fibroblasts derived from one of the individuals. We demonstrate that these ADAR2 variants lead to reduced editing activity on a known ADAR2 substrate. We also demonstrate that one variant leads to changes in splicing of ADARB1 transcript isoforms. These findings reinforce the importance of RNA editing in brain development and introduce ADARB1 as a genetic etiology in individuals with intellectual disability, microcephaly, and epilepsy.
Links
GA19-16963S, research and development project |
| ||
90062, large research infrastructures |
|